Jonathan Hirsch

Overview

Jonathan Hirsch is an angel investor based in San Francisco, California, focusing on early-stage healthcare and biotechnology companies. He is the founder and president of Syapse, a company dedicated to transforming cancer care through precision medicine and real-world evidence. In addition to his role at Syapse, Hirsch serves on the advisory boards of companies such as Freenome, VizAI, and PaigeAI, and has been involved in national cancer data sharing initiatives, including the White House Cancer Moonshot Data Sharing Working Group. As an active investor and partner in venture funds, including the Kleiner Perkins seed fund and Rebel Fund, Hirsch has incubated and invested in numerous companies at the intersection of healthcare and technology. His investment portfolio includes companies like Axle Health, Daybreak Health, OccamzRazor, Osmind, and Verifiable. He typically invests in the healthcare and medtech sectors, focusing on stages from pre-seed to growth, with investment sizes ranging from $25,000 to $2 million. Hirsch's approach combines his expertise in healthcare with a commitment to advancing innovative solutions in the industry. His strategic investments aim to support companies that are poised to make significant impacts in healthcare delivery and patient outcomes.